However, they observed a decline in spatial learning and increased neuronal loss in the hippocampus of rTg4510 mice overexpressing FKBP52, further highlighting the beneficial effects of FKBP52 inhibition in AD [259]. Here, FKBP4 is linked to Alzheimer disease.